Acquisition (code A) of 1,728 shares at $7.52 per share.
Reporting Person Farag Kameel D. · Officer Title Interim CFO · Transaction Code A
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001493152-26-039246 · filed 2026-08-19 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Akari Therapeutics Plc (AKTX)." Disclosed 2026-08-19. https://desqlong.com/cards/0001493152-26-039246-1 (retrieved 2026-09-26).